市場調査レポート

商品コード

1701711

抗生物質の市場規模、シェア、成長分析、薬剤クラス別、用途別、作用機序別、薬剤起源別、活性スペクトル別、投与経路別、地域別 - 産業予測 2025～2032年

Antibiotics Market Size, Share, and Growth Analysis, By Drug Class, By Application, By Action Mechanism, By Drug Origin, By Spectrum Of Activity, By Route of Administration, By Region - Industry Forecast 2025-2032

出版日: 2025年04月05日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 774,224円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 905,696円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,037,168円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

抗生物質の市場規模は2023年に452億米ドルで、予測期間（2025-2032年）のCAGRは4.8%で、2024年の473億7,000万米ドルから2032年には689億3,000万米ドルに成長する見通しです。

世界の医薬品市場は、特に革新的な製剤、併用療法、新規作用機序の領域で著しい進歩を遂げています。これらの技術革新は、増加する抗生物質耐性に対処し、進化する微生物の脅威がもたらす課題に適応するために極めて重要であり、各社が強力な研究開発努力を通じて感染症予防に献身していることを示すものです。アッヴィ、ファイザー、ノバルティス、メルク、テバなどの大手企業は、地理的プレゼンス拡大と新市場開発のため、積極的に合併・買収に取り組んでいます。さらに、臨床試験や薬事申請への投資が顕著に増加しており、抗生物質の開発コストが上昇しています。また、先進的な抗菌製剤の開発による製品の拡大も顕著であり、抗菌剤耐性の克服と治療効果の向上に向けた継続的な取り組みがうかがえます。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Pfizer Inc.（US）
GlaxoSmithKline plc.（GSK）（UK）
Merck & Co., Inc.（US）
Novartis AG（Switzerland）
Johnson & Johnson（US）
F. Hoffmann-La Roche AG（Switzerland）
AstraZeneca PLC（UK）
Bayer AG（Germany）
Abbott Laboratories（US）
Eli Lilly and Company（US）
Bristol-Myers Squibb Company（US）
Teva Pharmaceutical Industries Ltd.（Israel）
Astellas Pharma Inc.（Japan）
Cipla Ltd（India）
AbbVie, Inc.（US）
Lupin Pharmaceuticals, Inc.（US）
Viatris, Inc.（US）
Cipla, Inc.（US）
Shionogi & Co., Ltd.（Japan）
KYORIN Pharmaceutical Co., Ltd.（Japan）
Nabriva Therapeutics PLC（Ireland）

結論と提言

Product Code: SQMIG35B2164

Antibiotics Market size was valued at USD 45.2 billion in 2023 and is poised to grow from USD 47.37 billion in 2024 to USD 68.93 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).

The global pharmaceutical market is witnessing significant advancements, particularly in the realm of innovative drug formulations, combination therapies, and novel mechanisms of action. These innovations are crucial for addressing rising antibiotic resistance and adapting to challenges posed by evolving microbial threats, showcasing companies' dedication to infectious disease prevention through robust research and development efforts. Major players like AbbVie, Pfizer, Novartis, Merck, and Teva are actively engaging in mergers and acquisitions to expand their geographical presence and explore new markets. Additionally, there is a marked increase in investments in clinical trials and regulatory submissions, escalating the cost of antibiotic development. The market is also experiencing notable product expansion driven by the creation of advanced antimicrobial formulations, demonstrating an ongoing commitment to overcoming antimicrobial resistance and enhancing therapeutic efficacy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Antibiotics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Antibiotics Market Segments Analysis

Global Antibiotics Market is segmented by Drug Class, Application, Action Mechanism, Drug Origin, Spectrum Of Activity, Route of Administration, Distribution Channel and region. Based on Drug Class, the market is segmented into Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, 7-ACA and Others. Based on Application, the market is segmented into Skin infections, Urinary tract infection, Ear infection, Septicemia, Respiratory infections and Gastrointestinal infections. Based on Action Mechanism, the market is segmented into Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors and Others. Based on Drug Origin, the market is segmented into Natural and Synthetic. Based on Spectrum Of Activity, the market is segmented into Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic, By Route of Administration, Oral and Parenteral. Based on Route of Administration, the market is segmented into Oral and Parenteral. Based on Distribution Channel, the market is segmented into Retail pharmacies, Online pharmacies, Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Antibiotics Market

The antibiotics market is significantly driven by the rising prevalence of infectious diseases worldwide. Conditions such as respiratory infections, tuberculosis, urinary tract infections, and sexually transmitted diseases have seen a marked increase in cases, compounded by the growing concern of multidrug resistance. As new and more resistant bacterial strains emerge, healthcare professionals are under pressure to find effective antibiotic solutions to address these evolving challenges. This persistent demand for potent antibiotics to combat infections is a primary factor fueling the growth of the antibiotics market, highlighting the critical need for advancements in the development of these essential medications.

Restraints in the Antibiotics Market

A significant constraint on the antibiotics market is the escalating issue of antibiotic resistance. The proliferation of antibiotic use and misuse among humans and livestock has led to an alarming number of bacteria developing resistance to many current antibiotics. The World Health Organization (WHO) has identified antimicrobial resistance as a critical public health concern. As resistance continues to increase, the pool of effective antibiotics diminishes, posing challenges for the development of new treatments. This scenario not only restricts the application of existing antibiotics but also hampers market growth, necessitating substantial investment in research and development to combat this urgent problem.

Market Trends of the Antibiotics Market

The antibiotics market is witnessing a significant trend towards the increased focus on narrow-spectrum antibiotics, driven by the rising concern over antibiotic resistance and the side effects associated with broad-spectrum alternatives. As healthcare professionals prioritize targeted therapies that specifically address pathogenic bacteria, narrow-spectrum drugs are gaining traction for their ability to minimize collateral damage to beneficial microbiota. This shift not only enhances treatment efficacy but also plays a crucial role in conserving the effectiveness of existing antibiotics by reducing the potential for resistance development. Consequently, pharmaceutical companies are increasingly investing in research and development of narrow-spectrum formulations, shaping the future landscape of antibiotic therapy.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Antibiotics Market Size by Drug Class & CAGR (2025-2032)

Market Overview
Cephalosporin
Penicillin
Fluoroquinolone
Macrolide
Carbapenem
Aminoglycoside
Sulfonamide
7-ACA
Others

Global Antibiotics Market Size by Application & CAGR (2025-2032)

Market Overview
Skin infections
Urinary tract infection
Ear infection
Septicemia
Respiratory infections
Gastrointestinal infections

Global Antibiotics Market Size by Action Mechanism & CAGR (2025-2032)

Market Overview
Cell Wall Synthesis Inhibitors
Protein Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Mycolic Acid Inhibitors
Others

Global Antibiotics Market Size by Drug Origin & CAGR (2025-2032)

Market Overview
Natural
Synthetic

Global Antibiotics Market Size by Spectrum Of Activity & CAGR (2025-2032)

Market Overview
Broad-spectrum Antibiotic
Narrow-spectrum Antibiotic

Global Antibiotics Market Size by Route of Administration & CAGR (2025-2032)

Oral
Parenteral

Global Antibiotics Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Retail pharmacies
Online pharmacies
Hospitals
Clinics

Global Antibiotics Market Size & CAGR (2025-2032)

North America (Drug Class, Application, Action Mechanism, Drug Origin, Spectrum Of Activity, Route of Administration, Distribution Channel)

US

Canada

Europe (Drug Class, Application, Action Mechanism, Drug Origin, Spectrum Of Activity, Route of Administration, Distribution Channel)

Germany

Spain

France

UK

Italy

Rest of Europe

Asia Pacific (Drug Class, Application, Action Mechanism, Drug Origin, Spectrum Of Activity, Route of Administration, Distribution Channel)

China

India

Japan

South Korea

Rest of Asia-Pacific

Latin America (Drug Class, Application, Action Mechanism, Drug Origin, Spectrum Of Activity, Route of Administration, Distribution Channel)

Brazil

Rest of Latin America

Middle East & Africa (Drug Class, Application, Action Mechanism, Drug Origin, Spectrum Of Activity, Route of Administration, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc. (GSK) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bristol-Myers Squibb Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Ltd (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lupin Pharmaceuticals, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Viatris, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shionogi & Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
KYORIN Pharmaceutical Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nabriva Therapeutics PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

抗生物質の市場規模、シェア、成長分析、薬剤クラス別、用途別、作用機序別、薬剤起源別、活性スペクトル別、投与経路別、地域別 - 産業予測 2025～2032年

Antibiotics Market Size, Share, and Growth Analysis, By Drug Class, By Application, By Action Mechanism, By Drug Origin, By Spectrum Of Activity, By Route of Administration, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

抗生物質市場規模：薬剤クラス別& CAGR（2025-2032）

抗生物質市場規模：用途別& CAGR（2025-2032）

抗生物質市場規模：作用機序別& CAGR（2025-2032）

抗生物質市場規模：薬剤起源別& CAGR（2025-2032）

抗生物質市場規模：活性スペクトル別 & CAGR（2025-2032）

抗生物質市場規模：投与経路別& CAGR（2025-2032）

抗生物質市場規模：流通チャネル別& CAGR（2025-2032）

抗生物質市場規模& CAGR（2025-2032）